• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Postulosis palmoplantaris caused by angiotensin-converting enzyme inhibitors].

作者信息

Eriksen J G, Christiansen J J, Asmussen I

机构信息

Medicinsk afdeling, Nykøbing Mors Sygehus.

出版信息

Ugeskr Laeger. 1995 Jun 5;157(23):3335-6.

PMID:7631443
Abstract

Angiotensin-converting enzyme (ACE) is identical to kinase II, which inactivates bradykinin. Inhibition of bradykinin degradation by ACE inhibitors alters the kinin-kallikrein arachidonic acid system leading to increased concentrations of inflammatory metabolites. It has previously been demonstrated that the arachidonic acid system may play a role in the pathogenesis of psoriasis/volar pustulosis. Our patient was treated with Captopril and developed a rash identical to volar pustulosis within six weeks. Captopril was substituted with Perindopril, and the eruptions had almost disappeared five months later after a short systemic treatment with steroids. One month later the patient developed the same rash. Perindopril was withdrawn and the eruptions had disappeared two months later.

摘要

相似文献

1
[Postulosis palmoplantaris caused by angiotensin-converting enzyme inhibitors].
Ugeskr Laeger. 1995 Jun 5;157(23):3335-6.
2
[Initial manifestation of eruptive exanthematous psoriasis vulgaris caused by captopril medication].
Hautarzt. 1986 May;37(5):274-7.
3
Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
Can J Cardiol. 1994 Nov;10 Suppl D:13D-16D.
4
[Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus].
Vopr Med Khim. 1998 Mar-Apr;44(2):203-12.
5
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.血管紧张素II受体拮抗剂与心力衰竭:血管紧张素转换酶抑制剂仍是一线选择。
Prescrire Int. 2005 Oct;14(79):180-6.
6
ACE inhibitors and cough.血管紧张素转换酶抑制剂与咳嗽。
Angiology. 1994 Sep;45(9):805-8. doi: 10.1177/000331979404500908.
7
Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.充血性心力衰竭患者对首剂短效和长效血管紧张素转换酶抑制剂的血流动力学反应比较
Curr Med Res Opin. 2001;17(4):290-7.
8
Angiotensin-converting enzyme inhibitors and psoriasis.
N Z Med J. 1993 Sep 8;106(963):392-3.
9
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.心肌梗死大鼠中性内肽酶与血管紧张素转换酶抑制之间的相互作用:对心肌肥大以及血管紧张素和缓激肽肽水平的影响。
J Pharmacol Exp Ther. 1999 Apr;289(1):295-303.
10
Is there a role for bradykinin in the therapeutic and side effects of angiotensin-converting enzyme inhibitors?缓激肽在血管紧张素转换酶抑制剂的治疗作用及副作用中是否起作用?
Can J Cardiol. 1997 Feb;13(2):187-94.

引用本文的文献

1
A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence.血管紧张素转换酶抑制剂的使用与银屑病发病风险的系统评价和荟萃分析。
Sci Rep. 2021 May 11;11(1):10037. doi: 10.1038/s41598-021-89490-z.
2
Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature.接触血管紧张素转换酶抑制剂后的银屑病:法国药物警戒数据和文献复习。
Drug Saf. 2019 Dec;42(12):1507-1513. doi: 10.1007/s40264-019-00865-8.
3
Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.
晚期糖基化终产物受体的药理学调控及其在银屑病中的生物学效应
Int J Biomed Sci. 2013 Sep;9(3):112-22.